The cephalic phase of insulin release is modulated by IL-1β
- PMID: 35750050
- DOI: 10.1016/j.cmet.2022.06.001
The cephalic phase of insulin release is modulated by IL-1β
Abstract
The initial cephalic phase of insulin secretion is mediated through the vagus nerve and is not due to glycemic stimulation of pancreatic β cells. Recently, IL-1β was shown to stimulate postprandial insulin secretion. Here, we describe that this incretin-like effect of IL-1β involves neuronal transmission. Furthermore, we found that cephalic phase insulin release was mediated by IL-1β originating from microglia. Moreover, IL-1β activated the vagus nerve to induce insulin secretion and regulated the activity of the hypothalamus in response to cephalic stimulation. Notably, cephalic phase insulin release was impaired in obesity, in both mice and humans, and in mice, this was due to dysregulated IL-1β signaling. Our findings attribute a regulatory role to IL-1β in the integration of nutrient-derived sensory information, subsequent neuronally mediated insulin secretion, and the dysregulation of autonomic cephalic phase responses in obesity.
Keywords: CX3CR1+ cells; IL-1β; cephalic phase; inflammation; insulin; microglia; nutrition; obesity.
Copyright © 2022 The Authors. Published by Elsevier Inc. All rights reserved.
Conflict of interest statement
Declaration of interests M.Y.D. is listed as the inventor on a patent filed in 2003 for the use of an IL-1 receptor antagonist for the treatment of or prophylaxis for type 2 diabetes.
Comment in
-
A neuroimmunometabolic view on the cephalic phase of insulin release.Cell Metab. 2022 Jul 5;34(7):940-942. doi: 10.1016/j.cmet.2022.06.005. Cell Metab. 2022. PMID: 35793656
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Molecular Biology Databases